Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Scorpius Holdings, Inc (NYSE American:SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, ...

“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a groundbreaking advancement ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

Jeff Wolf, CEO of Scorpius Holdings ... (“Scorpius” or the “Company”), an integrated biomanufacturing company, today announced the implementation of strategic cost-saving measures expected ...

Scorpius BioManufacturing officials on Thursday told The Mercury ... “I think there’s a desire on everyone’s part to see this happen,” said Scorpius founder and CEO Jeff Wolf in a phone interview.

“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a ...

Scorpius BioManufacturing officials on Thursday ... s part to see this happen,” said Scorpius founder and CEO Jeff Wolf in a phone interview. “But you know, I think given the amount of time ...

DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development ...